SEC 13F Intelligence

Parkman Healthcare Partners LLC / PODD

Parkman Healthcare Partners LLC’s Insulet Corp Position

Does Parkman Healthcare Partners LLC own Insulet Corp (PODD)? Yes — 156.6K shares worth $33M (+3.39% of its 13F portfolio) as of Q1 2026, up from 140.9K shares the prior filed quarter.

Position Value
$33M
Q1 2026
Shares
156.6K
% of Portfolio
+3.39%
Quarters Held
24
currently held

Position History PODD

Reported value by quarter
Q2 ’20: $3MQ2 ’20Q3 ’20: $8MQ4 ’20: $8MQ1 ’21: $8MQ1 ’21Q2 ’21: $10MQ3 ’21: $10MQ4 ’21: $5MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ3 ’22: $4MQ3 ’22Q4 ’22: $5MQ1 ’23: $9MQ2 ’23: $17MQ2 ’23Q3 ’23: $7MQ4 ’23: $19MQ1 ’24: $16MQ1 ’24Q2 ’24: $36MQ3 ’24: $37MQ4 ’24: $33MQ4 ’24Q1 ’25: $34MQ2 ’25: $33MQ3 ’25: $36MQ3 ’25Q4 ’25: $40MQ1 ’26: $33Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026156.6K$33M+3.39%
Q4 2025140.9K$40M+3.81%
Q3 2025116.2K$36M+3.74%
Q2 2025105.8K$33M+3.82%
Q1 2025130.5K$34M+4.07%
Q4 2024125.8K$33M+4.37%
Q3 2024159.7K$37M+4.74%
Q2 2024179.3K$36M+4.85%
Q1 202490.9K$16M+1.91%
Q4 202388.7K$19M+2.71%
Q3 202342.0K$7M+1.23%
Q2 202358.1K$17M+2.90%
Q1 202328.7K$9M+1.99%
Q4 202218.0K$5M+1.41%
Q3 202217.1K$4M+1.11%
Q2 202213.9K$3M+1.11%
Q1 202212.7K$3M+0.99%
Q4 202117.0K$5M+1.00%
Q3 202134.3K$10M+2.47%
Q2 202135.3K$10M+2.12%
Q1 202131.2K$8M+1.89%
Q4 202030.6K$8M+2.00%
Q3 202032.5K$8M+2.04%
Q2 202017.5K$3M+0.96%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of PODD.